ArticleTurkish journal of medical sciences2026
Proximal fragment perfusion following hip arthroplasty with subtrochanteric shortening osteotomy in cases with severe developmental dysplasia of the hip.
Article in Turkish journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: The changes in proximal femoral blood flow occurring after reconstructive surgery for Crowe types III-IV developmental dysplasia of the hip (DDH) and their impact on healing remain unclear. In the present study, blood flow around the osteotomy site is evaluated with particular focus on the proximal segment in patients who underwent subtrochanteric shortening osteotomy and hip arthroplasty. To this end, single-photon emission computed tomography (SPECT/CT) scans were conducted to evaluate changes in proximal blood flow and to assess the impact on union rates and potential complications. Materials and methods: A retrospective analysis was conducted of 26 hips from a total of 20 patients with Crowe types III or IV DDH who underwent hip arthroplasty with subtrochanteric shortening osteotomy between July 2017 and September 2022. Planar, whole-body, and SPECT/CT images were reviewed by two nuclear medicine physicians, and the tracer uptake between the greater and lesser trochanters was assessed visually and quantitatively. Results: Assessed in the study were 26 hips of 20 patients (mean age 51.5 ± 8.8 years; 80.8% female) with a mean follow-up of 20.1 ± 10.1 months. Of the total, 14 hips were right-sided and 12 were left-sided; five and 21 were Crowe types III and IV, respectively. The union was timely (≤6 months) in 16 hips (61.5%), delayed in nine hips (34.6%), and nonunion in one hip (3.8%). After one year, 25 hips (96.2%) had achieved union. The mean femoral shortening was 3.8 ± 1.2 cm. SPECT/CT analysis revealed a mean SUV Conclusion: In patients with Crowe types III-IV DDH undergoing total hip arthroplasty, shortening osteotomies and soft tissue releases do not appear to significantly reduce vascularity or perfusion of the proximal osteotomy fragment. In our cohort, high union rates were observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.